Stoke Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC STOK

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

410,906

Value ($000)

13,042

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	13,042	0.0%	410,906	12/31/2025
2025 Q3	11/10/2025	9,468	0.0%	402,909	9/30/2025
2025 Q2	8/12/2025	3,868	0.0%	340,779	6/30/2025
2025 Q1	9/15/2025	2,064	0.0%	310,307	3/31/2025
2024 Q4	2/6/2025	3,774	0.0%	342,129	12/31/2024
2024 Q3	11/12/2024	3,885	0.0%	316,134	9/30/2024
2024 Q2	8/12/2024	3,908	0.0%	289,264	6/30/2024
2024 Q1	5/9/2024	3,011	0.0%	223,038	3/31/2024
2023 Q4	2/6/2024	1,080	0.0%	205,242	12/31/2023
2023 Q3	11/8/2023	856	0.0%	217,339	9/30/2023
2023 Q2	8/10/2023	2,199	0.0%	206,891	6/30/2023
2023 Q1	5/12/2023	1,364	0.0%	163,715	3/31/2023
2022 Q4	2/13/2023	1,522	0.0%	164,862	12/31/2022
2022 Q3	11/14/2022	2,084	0.0%	162,245	9/30/2022
2022 Q2	8/15/2022	2,188	0.0%	165,620	6/30/2022
2022 Q1	5/13/2022	3,173	0.0%	150,732	3/31/2022
2021 Q4	2/11/2022	3,546	0.0%	147,780	12/31/2021
2021 Q3	11/16/2021	3,715	0.0%	145,997	9/30/2021
2021 Q2	8/16/2021	4,599	0.0%	136,622	6/30/2021
2021 Q1	5/17/2021	4,753	0.0%	122,360	3/31/2021
2020 Q4	2/16/2021	7,184	0.0%	115,997	12/31/2020
2020 Q3	11/13/2020	3,140	0.0%	93,759	9/30/2020
2020 Q2	8/20/2020	1,523	0.0%	63,891	6/30/2020
2020 Q1	5/15/2020	1,613	0.0%	70,403	3/31/2020
2019 Q4	2/7/2020	1,499	0.0%	52,900	12/31/2019